Ashkenazi Jewish women who had changes in the BRCA1 or
BRCA2 genes were 28 percent less likely to die from the disease
over a follow-up period of up to nine years during the study
even though such mutations increase the chances of developing
breast or ovarian cancer in the first place, the researchers
said.
>> Read the Full Article